With 6 cGMP/ FDA inspected plants in Europe and the United States for commercial production supported by two pre-GMP (ISO 9001) sites in France, our customers have access to a powerful industrial network of facilities with a high level of quality, safety and environmental compliance.
Seqens invests on an ongoing basis in its production sites to provide the pharmaceutical industry with state-of-the-art equipment combined with cutting-edge technology in organic chemistry associated with proprietary gene shuffling technology for unique biocatalytic routes.
We conduct GMP manufacturing of APIs or intermediates from kilo to multi-ton quantities. Our range of scale and seamless collaboration within our manufacturing sites allow Seqens to accommodate most projects regardless of size and complexity.
Our services include:
- Process and analytical validation
- Kilo-scale, pilot scale and commercial multi-ton cGMP manufacturing
- Production in two locations for supply chain security
- Quality control and quality assurance
- Back integration of early intermediates for supply chain security, cost or quality control
- Special technologies like cryogenic, hydrogenation, biocatalysis
- HPAPI containment down to 100 ng/m3 OEL ( kilo scale to 200 kg batch size )
- Process optimization and second generation process for cost control
- Regulatory support and filings